Scinai Immunotherapeutics Ltd. (SCNI)
Scinai Immunotherapeutics Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Scinai Immunotherapeutics Ltd. (SCNI) is a Biotechnology company based in IL with a market capitalization of $604.8K. Free cash flow was negative at -$6.1M. This page tracks SCNI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
IL · 31 employees · IPO May 11, 2015
Valuation
Valuation & price
$0.54as of May 17, 2026· -73.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.07
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$604.8K
Market cap
—
Revenue growth (YoY)
-202.3%
Gross margin
-$6.1M
Free cash flow (USD)
$606K
Net debt
189.6%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2024 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jun 10, 2026 (EPS $0.94)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Annual reportJun 17, 2026Filing
Annual Report Filed
- Annual reportJun 15, 2026Filing
Annual Report Filed
- 6-K filingJun 8, 2026Filing
Notice to Shareholders
- 6-K filingMay 12, 2026Filing
Annual General Meeting Notice
- Annual reportMay 8, 2026Filing
Annual Report Filed
- 6-K filingApr 27, 2026Filing
Securities Purchase Agreement
- Annual reportApr 1, 2026Filing
20-F Filed
Questions
Frequently asked questions
What is Scinai Immunotherapeutics Ltd.'s market cap?
Scinai Immunotherapeutics Ltd. (SCNI) has a market capitalization of $604.8K.
What is SCNI's P/E ratio?
A meaningful P/E ratio is not available for SCNI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SCNI's price-to-book (P/B) ratio?
SCNI trades at 0.07 times book value per share.
When did Scinai Immunotherapeutics Ltd. last report earnings?
SCNI last reported earnings on June 10, 2026; the next date is not yet scheduled.
Are insiders buying SCNI stock?
SEC Form 4 filings show no open-market insider buys at Scinai Immunotherapeutics Ltd. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.